Feasibility of Surgery After Systemic Treatment with the Humanized Recombinant Antibody Bevacizumab in Heavily Pretreated Patients with Advanced Epithelial Ovarian Cancer

✍ Scribed by Jalid Sehouli; G. Papanikolaou; E.-I. Braicu; K. Pietzner; P. Neuhaus; C. Fotopoulou

• Book ID: 115031654
• Publisher: Springer
• Year: 2011
• Tongue: English
• Weight: 236 KB
• Volume: 19
• Category: Article
• ISSN: 1068-9265
• DOI: 10.1245/s10434-011-2134-0